Immix Biopharma, Inc. (IMMX) is driving high to 5.58% – Here’s the latest news
Immix Biopharma, Inc. (IMMX) experienced an increase of 5.58% in the premarket after the company announced positive IMX-110 Phase 1b/2a Interim Clinical Trial Safety Data.